- Full text PDF available (3)
- This year (5)
- Last 5 years (42)
- Last 10 years (43)
Journals and Conferences
Each differentiated cell type has its own epigenetic signature, which reflects its genotype, developmental history, and environmental influences, and is ultimately reflected in the phenotype of the… (More)
BACKGROUND Approximately 15%-30% of patients in trials of medical thromboprophylaxis will have missing compression ultrasound (CUS) data. The goal of the present analysis was to perform analyses to… (More)
Background: Extended thromboprophylaxis with full-dose betrixaban is effective in preventing venous thromboembolism (VTE). However, its effect on the hard endpoint of VTE-related mortality has not ...
BACKGROUND Anemia is a common finding and independent predictor for adverse outcomes in hospitalized patients with medical illness. It remains unclear whether anemia is a risk factor for venous… (More)
INTRODUCTION Andexanet alfa is a recombinant factor Xa decoy molecule that inhibits direct and indirect factor Xa inhibitors to allow the normal coagulation process to resume. Its development arises… (More)
Recurrent implantation failure (RIF) refers to failure to conceive after three or more in vitro fertilisation (IVF) or embryo transfer cycles. Implantation failure may be due to embryo or uterine… (More)
Background: While extended duration betrixaban has been associated with a reduction in the frequency of thrombus, it was hypothesized that it would reduce the extent of thrombus burden relative to ...
I t has been 30 years since the first report from the Framingham study demonstrated that silent or unrecognized myocardial infarction (MI), defined as evidence of MI on electrocardiography (ECG) in… (More)
AIM Asymptomatic deep vein thrombosis (DVT) diagnosed with compression ultrasound (CUS) is a common endpoint in trials assessing the efficacy of anticoagulants to prevent venous thromboembolism… (More)